TipRanks
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market
CMMB
Chemomab Therapeutics
RESEARCH TOOLSreports
Want to see CMMB full AI Analyst Report?

Chemomab Therapeutics (CMMB) Income Statement

328 Followers

Chemomab Therapeutics Income Statement

Last quarter (Q2 2026), Chemomab Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Chemomab Therapeutics's net income was $-2.20M. See Chemomab Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -66.83K$ -57.77K$ -34.02K
Operating Expenses
$ 9.57M$ 14.74M$ 25.46M$ 28.53M$ 12.34M
Depreciation and Amortization
$ 70.00K$ 53.00K$ 67.00K$ 57.77K$ 34.02K
EBITDA
$ -9.50M$ -14.69M$ -25.39M$ -28.48M$ -12.34M
Operating Income
$ -9.57M$ -14.74M$ -25.46M$ -28.53M$ -12.38M
Other Income/Expenses
$ 572.00K$ 794.00K$ 1.24M$ 353.00K$ -111.08K
Pretax Income
$ -8.99M$ -13.95M$ -24.22M$ -28.18M$ -12.49M
Net Income
$ -8.99M$ -13.95M$ -24.22M$ -27.65M$ -12.49M
Per Share Metrics
Basic EPS
$ -1.42$ -68.80$ -8.22$ -9.68$ -4.80
Diluted EPS
$ -1.42$ -68.80$ -8.22$ -9.68$ -4.80
Weighted Average Shares Outstanding
 6.38M 202.91K 2.94M 2.84M 2.59M
Weighted Average Shares Outstanding (Diluted)
 6.38M 202.91K 2.94M 2.84M 2.59M
Currency in USD

Chemomab Therapeutics Earnings and Revenue History